172 related articles for article (PubMed ID: 33547800)
1. Control of surge tanks for continuous manufacturing of monoclonal antibodies.
Thakur G; Nikita S; Tiwari A; Rathore AS
Biotechnol Bioeng; 2021 May; 118(5):1913-1931. PubMed ID: 33547800
[TBL] [Abstract][Full Text] [Related]
2. An NIR-based PAT approach for real-time control of loading in Protein A chromatography in continuous manufacturing of monoclonal antibodies.
Thakur G; Hebbi V; Rathore AS
Biotechnol Bioeng; 2020 Mar; 117(3):673-686. PubMed ID: 31788777
[TBL] [Abstract][Full Text] [Related]
3. Integrated continuous production of recombinant therapeutic proteins.
Warikoo V; Godawat R; Brower K; Jain S; Cummings D; Simons E; Johnson T; Walther J; Yu M; Wright B; McLarty J; Karey KP; Hwang C; Zhou W; Riske F; Konstantinov K
Biotechnol Bioeng; 2012 Dec; 109(12):3018-29. PubMed ID: 22729761
[TBL] [Abstract][Full Text] [Related]
4. Complete or periodic continuity in continuous manufacturing platforms for production of monoclonal antibodies?
Kateja N; Tiwari A; Thakur G; Rathore AS
Biotechnol J; 2021 Jul; 16(7):e2000524. PubMed ID: 33773062
[TBL] [Abstract][Full Text] [Related]
5. Process Analytical Technology (PAT) Implementation for Membrane Operations in Continuous Manufacturing of mAbs: Model-Based Control of Single-Pass Tangential Flow Ultrafiltration.
Thakur G; Masampally V; Kulkarni A; Rathore AS
AAPS J; 2022 Jul; 24(4):83. PubMed ID: 35831532
[TBL] [Abstract][Full Text] [Related]
6. A Cyber-Physical Production System for the Integrated Operation and Monitoring of a Continuous Manufacturing Train for the Production of Monoclonal Antibodies.
Thakur G; Nikita S; Yezhuvath VB; Buddhiraju VS; Rathore AS
Bioengineering (Basel); 2024 Jun; 11(6):. PubMed ID: 38927846
[TBL] [Abstract][Full Text] [Related]
7. Continuous manufacturing of monoclonal antibodies: Automated downstream control strategy for dynamic handling of titer variations.
Thakur G; Bansode V; Rathore AS
J Chromatogr A; 2022 Oct; 1682():463496. PubMed ID: 36126561
[TBL] [Abstract][Full Text] [Related]
8. Converting a mAb downstream process from batch to continuous using process modeling and process analytical technology.
Chen R; Chen XJ; Shi C; Jiao B; Shi Y; Yao B; Lin DQ; Gong W; Hsu S
Biotechnol J; 2022 Nov; 17(11):e2100351. PubMed ID: 35908168
[TBL] [Abstract][Full Text] [Related]
9. Continuous and Integrated Expression and Purification of Recombinant Antibodies.
Vogg S; Wolf MKF; Morbidelli M
Methods Mol Biol; 2018; 1850():147-178. PubMed ID: 30242686
[TBL] [Abstract][Full Text] [Related]
10. Continuous integrated antibody precipitation with two-stage tangential flow microfiltration enables constant mass flow.
Burgstaller D; Jungbauer A; Satzer P
Biotechnol Bioeng; 2019 May; 116(5):1053-1065. PubMed ID: 30636284
[TBL] [Abstract][Full Text] [Related]
11. Digital twin of a continuous chromatography process for mAb purification: Design and model-based control.
Tiwari A; Masampally VS; Agarwal A; Rathore AS
Biotechnol Bioeng; 2023 Mar; 120(3):748-766. PubMed ID: 36517960
[TBL] [Abstract][Full Text] [Related]
12. Continuous manufacturing of monoclonal antibodies: Dynamic control of multiple integrated polishing chromatography steps using BioSMB.
Nitika N; Thakur G; Rathore AS
J Chromatogr A; 2023 Feb; 1690():463784. PubMed ID: 36640682
[TBL] [Abstract][Full Text] [Related]
13. Design and operation of a continuous integrated monoclonal antibody production process.
Steinebach F; Ulmer N; Wolf M; Decker L; Schneider V; Wälchli R; Karst D; Souquet J; Morbidelli M
Biotechnol Prog; 2017 Sep; 33(5):1303-1313. PubMed ID: 28691347
[TBL] [Abstract][Full Text] [Related]
14. State-of-the-art in downstream processing of monoclonal antibodies: process trends in design and validation.
Marichal-Gallardo PA; Alvarez MM
Biotechnol Prog; 2012 Jul; 28(4):899-916. PubMed ID: 22641473
[TBL] [Abstract][Full Text] [Related]
15. Process performance and product quality in an integrated continuous antibody production process.
Karst DJ; Steinebach F; Soos M; Morbidelli M
Biotechnol Bioeng; 2017 Feb; 114(2):298-307. PubMed ID: 27497430
[TBL] [Abstract][Full Text] [Related]
16. Single pass diafiltration integrated into a fully continuous mAb purification process.
Rucker-Pezzini J; Arnold L; Hill-Byrne K; Sharp T; Avazhanskiy M; Forespring C
Biotechnol Bioeng; 2018 Aug; 115(8):1949-1957. PubMed ID: 29663323
[TBL] [Abstract][Full Text] [Related]
17. Enablers of continuous processing of biotherapeutic products.
Rathore AS; Zydney AL; Anupa A; Nikita S; Gangwar N
Trends Biotechnol; 2022 Jul; 40(7):804-815. PubMed ID: 35034769
[TBL] [Abstract][Full Text] [Related]
18. Process-wide control and automation of an integrated continuous manufacturing platform for antibodies.
Feidl F; Vogg S; Wolf M; Podobnik M; Ruggeri C; Ulmer N; Wälchli R; Souquet J; Broly H; Butté A; Morbidelli M
Biotechnol Bioeng; 2020 May; 117(5):1367-1380. PubMed ID: 32022243
[TBL] [Abstract][Full Text] [Related]
19. Implementation of Fully Integrated Continuous Antibody Processing: Effects on Productivity and COGm.
Arnold L; Lee K; Rucker-Pezzini J; Lee JH
Biotechnol J; 2019 Feb; 14(2):e1800061. PubMed ID: 29729129
[TBL] [Abstract][Full Text] [Related]
20. Side-by-side comparability of batch and continuous downstream for the production of monoclonal antibodies.
David L; Schwan P; Lobedann M; Borchert SO; Budde B; Temming M; Kuerschner M; Alberti Aguilo FM; Baumarth K; Thüte T; Maiser B; Blank A; Kistler V; Weber N; Brandt H; Poggel M; Kaiser K; Geisen K; Oehme F; Schembecker G
Biotechnol Bioeng; 2020 Apr; 117(4):1024-1036. PubMed ID: 31930482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
